Label Battles: Beovu And Eylea Contest Begins In AMD

Novartis's injectable anti-VEGF Beovu was approved for wet AMD by the US FDA

Elderly_Man_Eyesight
wet age-related macular degeneration affects 20 million people worldwide • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip